<DOC>
<DOCNO>EP-0655249</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Moenomycin as a medicament for the treatment of stomach ulcer
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3170	C07H1100	A61P100	A61K4500	A61P104	A61K4506	A61K3170	C07H1104	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	C07H	A61P	A61K	A61P	A61K	A61K	C07H	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	C07H11	A61P1	A61K45	A61P1	A61K45	A61K31	C07H11	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Moenomycin and its derivatives are suitable for preparation of medicaments for the treatment of stomach ulcers and for the control of Helicobacter pylori.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
HOECHST AG
</APPLICANT-NAME>
<APPLICANT-NAME>
HOECHST AKTIENGESELLSCHAFT
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
HEDTMANN DR UDO
</INVENTOR-NAME>
<INVENTOR-NAME>
RIESS DR GUENTER
</INVENTOR-NAME>
<INVENTOR-NAME>
SEIBERT PROF DR GERHARD
</INVENTOR-NAME>
<INVENTOR-NAME>
HEDTMANN, DR. UDO
</INVENTOR-NAME>
<INVENTOR-NAME>
RIESS, DR. GUENTER
</INVENTOR-NAME>
<INVENTOR-NAME>
SEIBERT, PROF. DR. GERHARD
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
The use of moenomycin and/or one or more of its
derivatives for the production of a pharmaceutical

for the control of gastric ulcers and for the
prophylaxis of cancer of the stomach.
The use of moenomycin and/or one or more of its
derivatives for the production of a pharmaceutical

for the control of Helicobacter pylori infections.
A pharmaceutical, which in addition to moenomycin
and/or one or more of its derivatives contains at

least one further agent against gastric ulcers
and/or an antibiotic.
A process for the production of a pharmaceutical as
claimed in claim 3, which comprises bringing moenomycin

and/or one or more of its derivatives into a
suitable form for administration with at least one

further agent against gastric ulcers and/or an
antibiotic, if appropriate using pharmacologically

tolerable auxiliaries and/or excipients.
</CLAIMS>
</TEXT>
</DOC>
